Herzer K - Search Results

1

Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.

Fontana RJ, Brown RS Jr, Moreno-Zamora A, Prieto M, Joshi S, Londoño MC, Herzer K, Chacko KR, Stauber RE, Knop V, Jafri SM, Castells L, Ferenci P, Torti C, Durand CM, Loiacono L, Lionetti R, Bahirwani R, Weiland O, Mubarak A, ElSharkawy AM, Stadler B, Montalbano M, Berg C, Pellicelli AM, Stenmark S, Vekeman F, Ionescu-Ittu R, Emond B, Reddy KR. Fontana RJ, et al. Among authors: herzer k. Liver Transpl. 2016 Apr;22(4):446-58. doi: 10.1002/lt.24416. Liver Transpl. 2016. PMID: 26890629 Free article.

2

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort.

Welzel TM, Petersen J, Herzer K, Ferenci P, Gschwantler M, Wedemeyer H, Berg T, Spengler U, Weiland O, van der Valk M, Rockstroh J, Peck-Radosavljevic M, Zhao Y, Jimenez-Exposito MJ, Zeuzem S. Welzel TM, et al. Among authors: herzer k. Gut. 2016 Nov;65(11):1861-1870. doi: 10.1136/gutjnl-2016-312444. Epub 2016 Sep 7. Gut. 2016. PMID: 27605539 Free PMC article.

3

Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease.

Herzer K, Welzel TM, Spengler U, Hinrichsen H, Klinker H, Berg T, Ferenci P, Peck-Radosavljevic M, Inderson A, Zhao Y, Jimenez-Exposito MJ, Zeuzem S. Herzer K, et al. Transpl Int. 2017 Mar;30(3):243-255. doi: 10.1111/tri.12910. Transpl Int. 2017. PMID: 28012215 Free article.

4

Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients.

Eisenberger U, Guberina H, Willuweit K, Bienholz A, Kribben A, Gerken G, Witzke O, Herzer K. Eisenberger U, et al. Among authors: herzer k. Transplantation. 2017 May;101(5):980-986. doi: 10.1097/TP.0000000000001414. Transplantation. 2017. PMID: 27495770

5

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.

Forns X, Berenguer M, Herzer K, Sterneck M, Donato MF, Andreone P, Fagiuoli S, Cieciura T, Durlik M, Calleja JL, Mariño Z, Shukla U, Verbinnen T, Lenz O, Ouwerkerk-Mahadevan S, Peeters M, Janssen K, Kalmeijer R, Jessner W. Forns X, et al. Among authors: herzer k. Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12696. Epub 2017 May 4. Transpl Infect Dis. 2017. PMID: 28295849 Clinical Trial.

6

Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant.

Papadopoulos-Köhn A, Achterfeld A, Paul A, Canbay A, Timm J, Jochum C, Gerken G, Herzer K. Papadopoulos-Köhn A, et al. Among authors: herzer k. Transplantation. 2015 Apr;99(4):841-7. doi: 10.1097/TP.0000000000000399. Transplantation. 2015. PMID: 25208324

7

Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver Transplant.

Herzer K, Papadopoulos-Köhn A, Walker A, Achterfeld A, Paul A, Canbay A, Timm J, Gerken G. Herzer K, et al. Digestion. 2015;91(4):326-33. doi: 10.1159/000382075. Epub 2015 May 19. Digestion. 2015. PMID: 25999053

8

The Effect of Immunosuppression on Coagulation After Liver Transplantation.

Bedreli S, Straub K, Achterfeld A, Willuweit K, Katsounas A, Saner F, Wedemeyer H, Herzer K. Bedreli S, et al. Among authors: herzer k. Liver Transpl. 2019 Jul;25(7):1054-1065. doi: 10.1002/lt.25476. Epub 2019 May 30. Liver Transpl. 2019. PMID: 31021493

9

Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.

Friebus-Kardash J, Gäckler A, Kribben A, Witzke O, Wedemeyer H, Treckmann J, Herzer K, Eisenberger U. Friebus-Kardash J, et al. Among authors: herzer k. Transpl Infect Dis. 2019 Oct;21(5):e13146. doi: 10.1111/tid.13146. Epub 2019 Jul 31. Transpl Infect Dis. 2019. PMID: 31306562

10

Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-Results from the German Hepatitis C-Registry.

Knop V, Mauss S, Goeser T, Geier A, Zimmermann T, Herzer K, Postel N, Friedrich-Rust M, Hofmann WP; German Hepatitis C-Registry. Knop V, et al. Among authors: herzer k. J Viral Hepat. 2020 Jul;27(7):690-698. doi: 10.1111/jvh.13280. Epub 2020 Mar 9. J Viral Hepat. 2020. PMID: 32096310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page